Innovative Treatments for Infectious Diseases
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: closed (15 February 2025)
Special Issue Editor
Interests: drug treatment; drug carrier systems; drug resistance; vaccine development and immunity to Leishmania
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Infectious diseases continue to pose a significant threat to global health, with the emergence of drug-resistant strains and novel pathogens that exacerbate the challenge. This Special Issue focuses on innovative treatments for infectious diseases, encompassing both experimental and clinical therapies. The rapid evolution of pathogens necessitates a dynamic approach to treatment, and this Special Issue explores the cutting-edge strategies being developed to combat these threats. The role of immunotherapies in bolstering the body's natural defenses against infections is underscored. This includes the development of vaccines that not only prevent disease but also treat existing infections, as well as therapies that enhance the immune response to pathogens.
The Special Issue aims to emphasize the importance of a multidisciplinary approach to the development of innovative treatments. The integration of insights from microbiology, immunology, pharmacology, and genomics is essential for the advancement of therapies that can effectively combat the ever-evolving landscape of infectious diseases.
Dr. Katharine Carter
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- innovative treatments
- infectious disease
- pathogens
- drug-resistant strains
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
